Australia Sepsis Diagnostics Market Size & Outlook
Australia sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Australia sepsis diagnostics market highlights
- The Australia sepsis diagnostics market generated a revenue of USD 17.9 million in 2022 and is expected to reach USD 41.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.2% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 17.9 million |
| Market revenue in 2030 | USD 41.8 million |
| Growth rate | 11.2% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.11% in 2022. Horizon Databook has segmented the Australia sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in Australia is expected to witness significant growth, driven by several crucial factors that highlight the increasing importance of early detection and effective management of this life-threatening condition.
According to estimates from the 2021 Australian Commission on Safety and Quality in Health Care, sepsis is a major concern within the Australian healthcare system, with over 48,000 hospital admissions annually where sepsis is the primary diagnosis.
In addition, sepsis is responsible for around 1,400 deaths annually, highlighting its severe impact on patient outcomes. These figures underscore the critical need for effective diagnostic tools and interventions to improve early detection & treatment, aiming to reduce the incidence & mortality associated with this life threatening condition.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia sepsis diagnostics market size, by product, 2018-2030 (US$M)
Australia Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
